COVID-19 vaccine to the rescue? ASX 200 up more than 2%
The ASX 200 (ASX:XJO) is up more than 2% today on potential COVID-19 vaccine news.
The Coronavirus (COVID-19) outbreak is weighing heavily on the Australian share market and S&P/ASX 200 (INDEXASX: XJO).
Follow Rask Media for the latest Coronavirus news, including companies that are currently being impacted (positive or negative) from the market crash.
Please note, we highly recommend that you read and follow closely the latest medical information from health.gov.au to keep you and your family as safe as possible. If you’re looking for financial support please free call the National Debt Helpline on: 1800 007 007. Alternatively, reach out to one of our team members, who will be able to point you towards free and helpful resources.
The ASX 200 (ASX:XJO) is up more than 2% today on potential COVID-19 vaccine news.
Virgin Australia (ASX:VAH) has moved onto the next stage of potentially being saved.
The Breville (ASX:BRG) share price is currently up 11% after the appliance business made a few announcements yesterday evening.
Xero (ASX:XRO) just released its FY20 result, is the share price a buy?
Is the CBA (ASX:CBA) share price a buy during COVID-19 after revealing its third quarter update?
Is the Kogan.com (ASX:KGN) share price a buy after reporting surging sales?
Altium (ASX:ALU) has announced COVID-19 troubles to investors, is the share price a buy?
Is the Suncorp (ASX:SUN) share price a buy after the financial business gave a COVID-19 update?
The Cochlear (ASX:COH) share price is on watch this morning after the hearing aid business announced a trading update.
The ASX 200 (ASX:XJO) is up more than 2% today on potential COVID-19 vaccine news.
Virgin Australia (ASX:VAH) has moved onto the next stage of potentially being saved.
The Breville (ASX:BRG) share price is currently up 11% after the appliance business made a few announcements yesterday evening.
Xero (ASX:XRO) just released its FY20 result, is the share price a buy?
Is the CBA (ASX:CBA) share price a buy during COVID-19 after revealing its third quarter update?
Is the Kogan.com (ASX:KGN) share price a buy after reporting surging sales?
Altium (ASX:ALU) has announced COVID-19 troubles to investors, is the share price a buy?
Is the Suncorp (ASX:SUN) share price a buy after the financial business gave a COVID-19 update?
The Cochlear (ASX:COH) share price is on watch this morning after the hearing aid business announced a trading update.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) and Target Market Determination before making a decision to acquire any financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
“Rask Invest” is considered a financial product and has a Product Disclosure Statement (PDS) and Target Market Determination (TMD), issued by InvestSMART. These documents can be accessed on the Rask Invest website. Please seek professional advice before making any investment decision with respect to Rask Invest.
© Rask Australia 2024